KEYNOTES

Sandra Pinho, PhD

Assistant Professor of Pharmacology

Dr. Sandra Pinho is an Assistant Professor of Pharmacology at the University of Illinois at Chicago. Dr. Pinho received her PhD at the Imperial College School of Medicine in London, England where she worked with Dr. Veronique Azuara in the Institute of Reproductive and Developmental Biology. She then did her postdoctoral work in the lab of Dr. Paul Frenette at Albert Einstein College of Medicine. While in Dr. Frenette’s lab she received a Druckenmiller Fellowship through the New York Stem Cell Foundation (NYSCF) and had first author publications in the Journal of Experimental Medicine and Developmental Cell. Dr. Her lab at the University of Illinois at Chicago is interested in understanding hematopoietic stem cell regulation, self-renewal, and differentiation, particularly the bone marrow microenvironment, using mouse bone marrow as a model system. Her hope is to be able to improve rejuvenation of aged hematopoietic stem cells, which will lead to improved cancer treatments for conditions such acute myeloid leukemia.

Sergei Doulatov, PhD

Associate Professor of Medicine / Hematology

Dr. Sergei Doulatov is an Associate Professor of Hematology and Adjunct Associate Professor of Genome Sciences at the University of Washington School of Medicine. Dr. Doulatov received his PhD in the lab of Dr. John Dick at the University of Toronto in Ontario, Canada in 2010, then did his postdoctoral research in the lab of Dr. George Daley at Harvard Medical School. His research focused on induction of multipotent hematopoietic progenitors from hiPSCs for engraftment and drug discovery to treat Diamond-Blackfan anemia, which produced first author publications in Science Translational Medicine and Cell Stem Cell. In 2016 he established his laboratory at the University of Washington School of Medicine, and in 2018 he received the New Innovator Award from the National Institute of Health to study epigenetic regulation of hematopoietic stem cell fate. Currently Dr. Doulatov’s lab focuses on using induced pluripotent stem cells to model myelodysplastic syndromes and to generate both hematopoietic stem cells and red blood cells.